pMD2-VSVGmut Citations (3)
Originally described in: Antigen identification and high-throughput interaction mapping by reprogramming viral entry.Dobson CS, Reich AN, Gaglione S, Smith BE, Kim EJ, Dong J, Ronsard L, Okonkwo V, Lingwood D, Dougan M, Dougan SK, Birnbaum ME Nat Methods. 2022 Apr;19(4):449-460. doi: 10.1038/s41592-022-01436-z. Epub 2022 Apr 8. PubMed Journal
Articles Citing pMD2-VSVGmut
| Articles |
|---|
| Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells. Xu EJK, Smith BE, Conce Alberto WD, Walsh MJ, Lim B, Hoffman MT, Qiang L, Dong J, Garmilla A, Zhao QH, Perez CR, Gaglione SA, Dobson CS, Dougan M, Dougan SK, Birnbaum ME. bioRxiv [Preprint]. 2024 Sep 22:2024.09.18.613594. doi: 10.1101/2024.09.18.613594. PubMed |
| Peptide-MHC-targeted retroviruses enable in vivo expansion and gene delivery to tumor-specific T cells. Xu EJK, Smith BE, Conce Alberto WD, Walsh MJ, Lim B, Hoffman MT, Qiang L, Barreiro A, Finburgh EN, Dong J, Garmilla A, Zhao QH, Perez CR, Gaglione SA, Dobson CS, Dougan M, Dougan SK, Birnbaum ME. Sci Adv. 2025 Nov 7;11(45):eadv2331. doi: 10.1126/sciadv.adv2331. Epub 2025 Nov 7. PubMed |
Scalable TCR synthesis and screening enable antigen reactivity mapping in vitiligo.
Gaglione SA, Mukkamala RS, Krishna C, Smith BE, Wadsworth MH 2nd, Jelinsky SA, Perez CR, Schmidt-Hong L, Katz EL, Gellatly KJ, Ali LR, Shen J, Holec PV, Zhao QH, Chan AO, Xu EJK, Kravarik KM, Guzova JA, Dobson CS, Singh H, Garber M, Dougan M, Dougan SK, Harris JE, Winkler A, Birnbaum ME.
Immunity. 2026 Feb 10;59(2):477-493.e9. doi: 10.1016/j.immuni.2026.01.001. Epub 2026 Jan 28.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.